Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConduit Hldg Regulatory News (CRE)

Share Price Information for Conduit Hldg (CRE)

Share Price is delayed by 15 minutes
Get Live Data
448.00    3.00 (0.67%)
Bid:
447.50
Ask:
449.00
Spread: 1.50 (0.335%)
Market Cap: £662.61m
CRE Live PriceLast checked at - London Stock Exchange

Intraday Conduit Hldg Share Chart

Interim Management Statement

3 Feb 2009 07:00

RNS Number : 6484M
Creston PLC
03 February 2009
 



3 February 2009

Creston plc 

Interim Management Statement 

Creston plc (LSE: CRE), the Insight and Communications Group, announces its interim management statement for the period 1 April 2008 to 2 February 2009.

Financial Performance Indicators

Trading for the nine months ending December 2008 have been in line with the Board's expectations and demonstrate growth during a difficult economic environment:

Revenue growth of 4%

Headline operating profit margin after head office costs of 18% (2008: 18%) 

Operating cash conversion from EBITDA of 97 percent. 

Headline performance measures exclude the impact of the non-recurring charges outlined in the Company's Interim statement.

New Business

In the Interim statement for the six months ending September 2008, the Group announced net new business revenue annualised at £11m (2008: £5m). This excellent new business performance has continued to date with further wins across both Divisions, which include Boehringer Ingelheim, COI (Stroke Awareness), Unilever (Lynx), Services at Home, Spicers and Xchanging. As the new calendar year starts, there continues to be a good pipe line of new business opportunities across the Group and recent wins that will be announced shortly.

Operational Trading

The Board's business objectives remain unchanged with a focus on reducing debt and maintaining upper quartile key performance indicators (KPIs), such as revenue per head, operating profit margin and cash conversion. As noted above the cash conversion on EBITDA for the nine months has been good and the reduction in net debt remains in line with the Board's expectations.

As reported in the Group's Interim statement, only 21 per cent of the Group's revenue is in advertising and over 70 per cent in direct and digital marketing, healthcare marketing and market research. This diversification towards more resilient areas of the marketing industry has benefited the Group as demonstrated in the financial performance noted above.

The Communications Division has benefited from its weighting towards direct and digital marketing and offering integrated on and off line communication. This Division continues to achieve strong year on year growth driven by an excellent new business performance.

Trading for the Insight Division continues to be robust in the larger companies ICM and Marketing Sciences. However, as reported in the Interims the niche discipline of qualitative market research continues to experience a year-on-year decline and the Company has taken the necessary steps to align costs and structure to the trading outlook.

Outlook

The Board is realistic about the tough trading environment the UK economy faces and as the Group prepares for the new financial year, it will reduce its operating cost base where necessary, so its KPIs remain in line. Based on the nine month trading performance to the end of December 2008, the Group remains on course to meet the Board's expectations for the current financial year

For further information, please contact:

Creston plc

020 7930 9757

Don Elgie, Chief Executive

Barrie Brien, COO/CFO

www.creston.com 

Hogarth Partnership Limited

020 7357 9477

Chris Matthews/Anthony Arthur/ Fiona Noblet

 

About Creston plc

Creston is an Insight and Communications marketing services group. The Board's aim is to identify synergistic benefits between its marketing services companies offering premium services such as market research, direct and interactive marketing, advertising, public relations, insight; and to build a Group that offers effective and accountable marketing solutions across both on-line and off-line channels. 

Creston's companies boast a range of blue-chip clients including the Amazon, AstraZeneca, Bayer, BMW, BT, Burger King, Canon, COI Communications, Cow & Gate, Daily Mirror, Diageo, eBay, First Direct, General Motors, GlaxoSmithKline, Halifax, Homeform, House of Fraser, Kimberly-Clark, Lexus, Lloyds Black Horse, Morrisons, NHS Lottery, Nissan, Norwich Union, Pfizer, Roche DiagnosticsRoyal Mail, SAB Miller, Sainsbury's, Tesco, Thorpe Park, Toshiba, Trinity Mirror, T-Mobile, Tropicana, Unilever, Vodafone, Walkers and WH Smith.

Creston's share price is quoted in the Financial Times, The Daily Telegraph, The Times and the London Evening Standard.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSEALAAELXNEFE
Date   Source Headline
16th May 20254:48 pmRNSDirector/PDMR Shareholding
14th May 20255:57 pmRNSResult of AGM
14th May 20255:51 pmRNSDirector/PDMR Shareholding
14th May 20257:00 amRNSCEO appointment and Directorate Changes
14th May 20257:00 amRNSTrading Update for Q1 2025
6th May 20257:00 amRNSNotice of Q1 2025 Trading Update
22nd Apr 20257:00 amRNSAppointment of Interim CUO
10th Apr 20255:07 pmRNSNotice of AGM
10th Apr 20254:40 pmRNSHolding(s) in Company
10th Apr 20254:39 pmRNSPurchase of Shares by Employee Benefit Trust
9th Apr 20255:49 pmRNSDirector/PDMR Shareholding
9th Apr 20255:33 pmRNSPurchase of Shares by Employee Benefit Trust
8th Apr 20252:59 pmRNSPurchase of Shares by Employee Benefit Trust
7th Apr 20251:28 pmRNSPurchase of Shares by Employee Benefit Trust
4th Apr 20255:27 pmRNSPurchase of Shares by Employee Benefit Trust
4th Apr 20251:21 pmRNSDirector/PDMR Shareholding
3rd Apr 20253:22 pmRNSDirector/PDMR Shareholding
3rd Apr 20253:08 pmRNSPurchase of Shares by Employee Benefit Trust
2nd Apr 20255:10 pmRNSHolding(s) in Company
2nd Apr 20255:09 pmRNSPurchase of Shares by Employee Benefit Trust
1st Apr 20256:20 pmRNSDirector/PDMR Shareholding
31st Mar 20257:00 amRNSCEO Retirement
26th Mar 20255:54 pmRNSDirector/PDMR Shareholding
26th Mar 20255:51 pmRNSDirector/PDMR Shareholding
26th Mar 20255:50 pmRNSDirector/PDMR Shareholding
26th Mar 20255:50 pmRNSDirector/PDMR Shareholding
26th Mar 20255:45 pmRNSDirector/PDMR Shareholding
26th Mar 20255:44 pmRNSDirector/PDMR Shareholding
26th Mar 20255:43 pmRNSDirector/PDMR Shareholding
26th Mar 20255:43 pmRNSDirector/PDMR Shareholding
14th Mar 202512:20 pmRNSNotification of Major Holdings
14th Mar 202512:19 pmRNSNotification of Major Holdings
11th Mar 202512:22 pmRNSNotification of Major Holdings
27th Feb 20258:00 amRNSPublication of 2024 Annual Report and Accounts
25th Feb 20257:00 amRNSDirector/PDMR Shareholding
24th Feb 20257:00 amRNSDirector/PDMR Shareholding
19th Feb 20257:00 amRNSPreliminary results for the year ended 31/12/24
30th Jan 20257:00 amRNSNotice of Results
18th Dec 20247:00 amRNSComment on AM Best ratings outlook
15th Nov 20247:00 amRNSDirector/PDMR Shareholding
13th Nov 20245:35 pmRNSDirector/PDMR Shareholding
8th Nov 20245:16 pmRNSDirector/PDMR Shareholding
8th Nov 20245:16 pmRNSDirector/PDMR Shareholding
8th Nov 20247:00 amRNSDirector/PDMR Shareholding - Amendment
7th Nov 20244:26 pmRNSDirector/PDMR Shareholding
6th Nov 20247:00 amRNSTrading Statement
23rd Oct 20243:02 pmRNSNotice of Results
4th Sep 20243:36 pmRNSDirector/PDMR Shareholding
14th Aug 20247:00 amRNSDirector/PDMR Shareholding
31st Jul 20247:00 amRNSInterim Results for the six months to 30/06/2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.